drugset / Trial / NCT03886896

Intravenous Lidocaine in Children Undergoing Laparoscopic Appendectomy

NCT03886896 ↗

Phase 4 Completed 74 enrolled Medical University of Warsaw
RandomizedParallel-groupSingle-blindSupportive care

Summary

Intravenous lidocaine - a potent local anesthetic with analgesic and anti-inflammatory properties has been shown to be an effective adjunct that reduces intra and postoperative opioid consumption and facilitates pain management in adults. In children population promising but limited evidence is available. The study was planned to evaluate the efficacy of continuous intravenous infusion of lidocaine to reduce opioid consumption during and after laparoscopic appendectomy in children.

Timeline

Start
2019-03-22
Primary completion
2020-01-15
Completion
2020-01-17

Outcome

Missed primary endpoint

paper There was no difference in the cumulative dose of nalbuphine in the first 24 h after removal of the endotracheal tube between groups PMID 33397287 ↗

paper control group median of 0.1325 (IQR: 0.0899-0.22020) mg/kg, p = 0.63). PMID 33397287 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications